Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01)

Authors

Institutions

Publication Details

Journal
Future Oncology
Published
2025-08-25
DOI
https://doi.org/10.1080/14796694.2025.2549244
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01)

Rami Nasr, Raja B. Khauli, Noura Abbas, Monita Al Darazi et al.
1 links
Future Oncology
Bladder and Urothelial Cancer Treatments
article

Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01)

Rami Nasr, Raja B. Khauli, Noura Abbas, Monita Al Darazi, Muhammad Bulbul, Ali Shamseddine, Albert El Hajj, Maya Charafeddine, Sally Temraz, B.Y. Youssef, Kristel Dagher
article en

Abstract

No abstract available for this paper.
Future OncologyVol. 21(30)
American University of Beirut Medical Center (LB)
Merck
Zero hunger
Openalex Percentile: Top 64%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.